Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GM | Common Stock | Options Exercise | $3.1M | +99K | +85.26% | $31.32 | 215K | Jun 7, 2021 | Direct | F1 |
transaction | GM | Common Stock | Sale | -$6.34M | -99K | -46.02% | $64.00 | 116K | Jun 7, 2021 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GM | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -99K | -34.65% | $0.00 | 187K | Jun 7, 2021 | Common Stock | 99K | $31.32 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. |
F2 | The price in Column 4 is the weighted average selling price of the shares. The shares were sold in multiple transactions at prices from $63.81 to $64.28, inclusive. The Reporting Person undertakes to provide to the SEC, GM and any security holder, upon request, full information regarding the number of shares sold at each price point within the ranges set forth in this footnote. |
F3 | On July 28, 2015, the Reporting Person was granted 345,705 Stock Options: 40% vested on February 2017, the remaining 60% became exercisable in three equal installments on February 15, 2018, February 15, 2019, and February 15, 2020. |